累及喉部的进行性结节性组织细胞增生症1例并文献复习

doi:10.6040/j.issn.1673-3770.0.2021.140

摘要/Abstract

摘要： 目的探讨1例罕见的累及喉部的进行性结节性组织细胞增生症的诊疗过程、临床及病理特点。方法提取患者的病例资料、病理切片,对切片进行免疫组化染色观察,总结本病历的特点并查询PNH相关文献。结果本病历中患者的病理提示梭形细胞弥漫浸润,免疫组化显示CD68和CD163阳性。患者出现声门上狭窄、气管壁增厚、气管内多发结节,曾因呼吸困难行气管切开,累及皮肤形成多发结节,面部结节形成“狮面”外观,确诊后予以安罗替尼药物治疗可减缓病情发展。结论该病通过病理检查确诊,可累及喉部引起呼吸困难,面部结节除非严重影响功能,不主张手术切除皮损。

关键词: 组织细胞增生症, 非肿瘤性增生性皮肤病, 非朗格汉斯细胞组织细胞增生症, 喉

Abstract: Objective To explore the diagnosis and treatment, the clinical characteristic, as well as the pathological features, of a rare case of progressive nodular histiocytosis involving the larynx. Methods Patient case data, pathological sections were extracted and observed by immunohistochemical staining to summarize the characteristics of this case and to consult the literature related to PNH. Results The pathology of the patient in this case suggested a diffuse infiltration of spindle cells, and immunohistochemistry was positive for CD68 and CD163. The patient presented with supraglottic stenosis, thickening of the tracheal wall, and multiple nodules in the trachea. The patient had undergone a tracheotomy due to dyspnea. This disease involves the skin, and it manifests in multiple nodules and facial nodules that give rise to a “lion face” appearance. After diagnosis, treatment with anlotinib can delay the development of this disease. Conclusion The disease is diagnosed based on pathological examination. It can involve the larynx and cause breathing difficulties. Surgical removal of the facial nodules is not recommended unless body function is seriously affected.

Key words: Histiocytosis, Non-neoplastic proliferative skin disease, Non-Langerhans cell histiocytosis, Laryngeal

中图分类号:

R758.6

廖静雯,陈敏,李娜,黄沂传,赵涵. 累及喉部的进行性结节性组织细胞增生症1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 35-39.

LIAO Jingwen, CHEN Min, LI Na, HUANG Yichuan, ZHAO Han. Laryngeal involvement in progressive nodular histiocytosis: a case report with literature review[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 35-39.

参考文献

[1] Taunton OD, Yeshurun D, Jarratt M. Progressive nodular histiocytoma[J]. Arch Dermatol, 1978, 114(10): 1505-1508.
[2] 渠涛, 方凯. 进行性结节性组织细胞增生症[J]. 临床皮肤科杂志, 2015,44(9): 555-558. doi:10.16761/j.cnki.1000-4963.2015.09.022. QU Tao, FANG Kai. Progressive nodular Histiocytosis: a case report and literature review[J]. J Clin Dermatol, 2015,44(9): 555-558. doi:10.16761/j.cnki.1000-4963.2015.09.022.
[3] Chu AC. The confusing state of the histiocytoses[J]. Br J Dermatol, 2000, 143(3): 475-476. doi:10.1111/j.1365-2133.2000.03821.x.
[4] Glavin FL, Chhatwall H, Karimi K. Progressive nodular Histiocytosis: a case report with literature review, and discussion of differential diagnosis and classification[J]. J Cutan Pathol, 2009, 36(12): 1286-1292. doi:10.1111/j.1600-0560.2009.01454.x.
[5] Amin SM, Riddle C, Fraga GR, et al. Progressive nodular Histiocytosis with normal karyotypic analysis[J]. Dermatol Online J, 2013, 19(6): 18577.
[6] Nofal A, Assaf M, Tawfik A, et al. Progressive nodular Histiocytosis: a case report and literature review[J]. Int J Dermatol, 2011, 50(12): 1546-1551. doi:10.1111/j.1365-4632.2011.04904.x.
[7] Hilker O, Kovneristy A, Varga R, et al. Progressive nodular Histiocytosis[J]. J Ger Soc Dermatol: JDDG, 2013, 11(4): 301-307. doi:10.1111/j.1610-0387.2012.08069.x.
[8] Bratschi MW, Steinmann P, Wickenden A, et al. Current knowledge on Mycobacterium leprae transmission: a systematic literature review[J]. Lepr Rev, 2015, 86(2): 142-155.
[9] 程海星, 葛兰, 翟志芳, 等. 肉芽肿性蕈样肉芽肿[J]. 临床皮肤科杂志, 2019,48(12): 749-751. doi:10.16761/j.cnki.1000-4963.2019.12.013. CHENG Haixing, GE Lan, ZHAI Zhifang, et al. A case of granulomatous mycosis fungoides[J]. J Clin Dermatol, 2019,48(12): 749-751. doi:10.16761/j.cnki.1000-4963.2019.12.013.
[10] Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome[J]. Am J Respir Crit Care Med, 2003, 168(10): 1162-1166. doi:10.1164/rccm.200303-456OC.
[11] 王晓琴, 程岩峰, 韩秀萍. 皮肤结节病12例诊断与误诊分析[J]. 中国误诊学杂志, 2011, 11(3): 638.
[12] Gonzalez Ruíz A, Bernal Ruíz AI, Aragoneses Fraile H, et al. Progressive nodular Histiocytosis accompanied by systemic disorders[J]. Br J Dermatol, 2000, 143(3): 628-631. doi:10.1111/j.1365-2133.2000.03723.x.
[13] Watanabe T, Watanabe D, Tamada Y, et al. Progressive nodular Histiocytosis-A five-year follow up[J]. Eur J Dermatol, 2008, 18(2): 200-202. doi:10.1684/ejd.2008.0370.
[14] Huet F, Brenaut E, Costa S, et al. Progressive nodular Histiocytosis improved by methotrexate[J]. Eur J Dermatol, 2017, 27(6): 661-663. doi:10.1684/ejd.2017.3115.
[15] Williams A, Thomas AG, Kwatra KS, et al. Progressive nodular Histiocytosis associated with eale's disease[J]. Indian J Dermatol, 2015, 60(4): 388-390. doi:10.4103/0019-5154.160492.
[16] 王俊, 冉凤鸣, 金兵. 安罗替尼治疗恶性肿瘤的临床研究进展[J]. 中国肿瘤, 2019, 28(5): 359-366. doi:10.11735/j.issn.1004-0242.2019.05.A008. WANG Jun, RAN Fengming, JIN Bing. Progress on clinical research of anlotinib in cancer treatment[J]. China Cancer, 2019, 28(5): 359-366. doi:10.11735/j.issn.1004-0242.2019.05.A008.
[17] Wang LL, He Z, Yang S, et al. The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer(NSCLC): a subgroup analysis of ALTER0303 trial[J]. Transl Lung Cancer Res, 2019, 8(5): 575-583. doi:10.21037/tlcr.2019.09.21.
[18] Chi Y, Fang ZW, Hong XN, et al. Safety and efficacy of anlotinib, a multikinase angiogenesis inhibitor, in patients with refractory metastatic soft-tissue sarcoma[J]. Clin Cancer Res, 2018, 24(21): 5233-5238. doi:10.1158/1078-0432.CCR-17-3766.

相关文章 15

[1]	肖俊华,潘庆春,晋舒. 基于全球疾病负担数据库分析职业硫酸暴露下喉癌患者的死亡趋势[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 55-61.
[2]	徐娟,崔彪,黄建平,陈以标,施建飞,王燕雯,刘赞华,张剑伟. 电子喉镜评估老年肺部感染患者的吞咽功能[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 74-79.
[3]	章娜娜,黄冠江,卢标清. 联合中医证型分析喉癌变的影响因素及构建预测模型[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 29-37.
[4]	程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119.
[5]	刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137.
[6]	刘丹凤,潘庆春,李代波,封雪飞,任健. 1990—2021年中国归因于过量饮酒的喉癌疾病负担分析及未来趋势预测[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 61-69.
[7]	刘玉柱,苑铁君,李波. 会厌原发神经内分泌癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 97-100.
[8]	胡祎,孔旭辉. 补体在喉鳞状细胞癌发生发展中作用机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 148-155.
[9]	沈文浩,陈曦. 双能CT在喉鳞状细胞癌诊疗中的运用[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 156-160.
[10]	石金莲,李建兴,黄幼生,林铭轩,刘灵云,卢永田. 喉部炎性肌纤维母细胞瘤的研究现状与诊疗进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 186-192.
[11]	倪凌达,唐旭兰,孟丽丽,周慧群,苏开明. 电子鼻咽喉镜中I-scan各模式与白光模式的应用比较[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 19-25.
[12]	李芃泽,于霜,王加锋. 男性喉局部淀粉样变发生与谷丙转氨酶异常相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 135-140.
[13]	杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[14]	谢枫,许贞菊,吴策,刘杰,臧传善,张龙宵,韩敏. 喉神经内分泌肿瘤26例临床病理特征及生存分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 79-86.
[15]	曲翔宇,朱晗,柳忠禄,牟亚魁,郭文涛,张华. 会厌舌瓣在喉癌声门上缺损修复术中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 77-84.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed